Undoubtedly, ADXS has a lot of things not to like from an investment standpoint. Yet I am long a modest-sized position because I think the NEO program licensed by AMGN has promise and, by itself, justifies ADXS's enterprise value (~$275M at a share price of $8).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”